VHCP Management III as of Dec. 31, 2018
Portfolio Holdings for VHCP Management III
VHCP Management III holds 15 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kalvista Pharmaceuticals (KALV) | 18.4 | $25M | 1.3M | 19.75 | |
| BioCryst Pharmaceuticals (BCRX) | 18.0 | $25M | 3.1M | 8.07 | |
| Orchard Therapeutics Plc ads | 11.9 | $16M | 1.0M | 15.73 | |
| Tricida | 11.2 | $15M | 651k | 23.58 | |
| Obseva Sa | 10.7 | $15M | 1.2M | 12.66 | |
| Ra Pharmaceuticals | 7.9 | $11M | 595k | 18.20 | |
| Kiniksa Pharmaceuticals (KNSA) | 6.7 | $9.2M | 328k | 28.09 | |
| Kadmon Hldgs | 3.6 | $5.0M | 2.4M | 2.08 | |
| Dbv Technologies S A (DBVT) | 3.0 | $4.1M | 637k | 6.42 | |
| Marinus Pharmaceuticals | 2.6 | $3.6M | 1.3M | 2.87 | |
| Protagonist Therapeutics (PTGX) | 2.1 | $2.8M | 423k | 6.73 | |
| Proteostasis Therapeutics In | 2.0 | $2.7M | 849k | 3.24 | |
| Bellerophon Therapeutics | 1.3 | $1.8M | 2.3M | 0.80 | |
| Gemphire Therapeutics | 0.5 | $704k | 870k | 0.81 | |
| Constellation Pharmceticls I | 0.2 | $267k | 67k | 4.00 |
